Recruiting

Biofield Patch

Sponsor:

Natural Immune Systems Inc

Code:

NCT07353021

Conditions

Anxiety

Sleep

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Interventions

Active dermal patch

Placebo patch

Study Details

Brief summary:

The goal for this clinical trial is to compare an active biofield non-transdermal skin patch to a placebo patch in people who frequently experience anxiety.

Conditions

Anxiety

Sleep

Study ID

NCT07353021

Start date

Oct 23, 2026

Status verified date

Jan, 2026

Completion date

Sep, 2027

Anticipated

Primary completion date

Jun, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Healthy adults of all genders;
  • Age 18-75 years (inclusive);
  • BMI between 18.0 and 34.9 (inclusive)
  • Experiencing intermittent episodes of anxiety on a regular basis, leading to either avoiding specific situations, or experiencing stress both in anticipation of, and during such situations.

  • Specific situations that occur regularly that cause anxiety, for example:

  • Performing specific tasks at work or at home;
  • Inter-personal conflicts at work or at home;
  • Driving or commuting;
  • Fearful and worrying about one's own situation (such as paying bills);
  • Worrying about ongoing problems experienced by others.

Exclusion Criteria:

  • Cancer during past 12 months;
  • Chemotherapy during past 12 months;
  • Currently taking anxiolytic, hypnotic, or anti-depressant prescription medication;
  • Currently taking nutritional supplements judged by the study coordinator to negate or camouflage the effects of the test product;
  • Participation in another clinical trial study during this trial, involving an investigational product or lifestyle change;
  • Serious active illness within past 6 months;
  • People who are pregnant, nursing, or trying to become pregnant.

Study Design

Enrollment

40 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Basic Science

Interventions and Outcome Measures

Arms

experimental: Group 1

Participants will use an active biofield patch daily for 4 weeks. The active biofield patch will look identical to a placebo patch, and will be blinded.

experimental: Group 2

Participants will use a placebo patch daily for 4 weeks. The placebo patch will look identical to an active patch, and will be blinded.

Interventions

Active dermal patch

Non-transdermal patch

Placebo patch

Non-transdermal patch

Primary outcome measure

  • General Anxiety Disorder 7 (GAD 7) Questionnaire [ Time Frame: Baseline, 1 week, 2 weeks, 3 weeks, 4 weeks ]

Central Contacts and Locations

Central contacts

Gitte S Jensen, PhD

541 882 0112Gitte@nislabs.com

Alex Cruickshank

Alex@nislabs.com

Locations

NIS Labs

Recruiting

Klamath Falls, Oregon, United States, 97601

Contacts

Gitte S. Jensen, PhD

5418840112gitte@nislabs.com

More Information

Sponsor

Natural Immune Systems Inc

Last update posted

Nov 12, 2026

Last verified

Jan, 2026

Keywords

  • Sleep
  • Stress
  • Anxiety

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-13. This information was provided to ClinicalTrials.gov by Natural Immune Systems Inc on 2026-11-12. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.